Safety of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials

Related

• 

  Platform for Screening Compounds for Treatment of AMD Using iPSC-derived human RPE: Examples Using Elamipretide and SBT-272

  Lucian V. Del Priore, MD, PhD

  Annual Meeting Talks

  2022

• 

  GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

  Jeffrey S. Heier, MD

  Arshad M. Khanani, MD, MA, FASRS

  Updates from the Field

  2022

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024